The CTC offices are currently closed for refurbishment. Access to trial TMFs and patient records will be limited during this period. We will still be able to receive post during this time, but there may be a small delay in responding to this. Our fax lines may also be subject to disruption. Where possible, please direct all correspondence via email to trial-specific email addresses. We appreciate your patience and understanding.
Due to COVID-19 and current government guidance, UCL CTC staff continue to work remotely with limited access to the office. Please continue to email the trial specific mailbox with any urgent queries. For paper CRF trials, please continue to copy and scan CRFs to the trial inboxes (remove all patient identifiers except Trial Number and Initials) until further notice.
Combination immunotherapy for metastatic prostate cancer shows promise
A combination of two antibody therapeutics - nivolumab and ipilimumab - has achieved the best response yet seen in the treatment of metastat [...]
Easter closure dates
The CTC will be closed from Thursday 2nd - Friday 9th April 2021 inclusive*. During the closure period there will be limited staff cover in [...]
CTC study in lung cancer screening breakthrough
The major London lung cancer screening study SUMMIT has announced findings with potentially huge implications for the treatment of lung canc [...]
Promising results for innovative radiotherapy treatment as CTC study gets virtual presentations
When the 25th annual CTOS (Connective Tissue Oncology Society) meeting took place virtually at the end of last year (18-21 November), attend [...]
Copyright © 2021 UCL | Disclaimer | Freedom of Information | Accessibility | Privacy | Cookies | Contact Us